Breaking News

ExcellGene, Cytovance Partner to Advance Biologics Development and Manufacture

Will combine ExcellGene’s transposon technologies with Cytovance’s cGMP manufacturing expertise.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

ExcellGene SA, a Swiss biotech service provider specializing in mammalian cell line development, has entered a strategic collaboration with Cytovance Biologics, a CDMO based in the U.S., to advance large molecule biologics development and manufacture.   Leveraging CHO (Chinese Hamster Ovary) and HEK (Human Embryonic Kidney) cells for mammalian cell lines for recombinant protein production and biological research, this partnership aims to advance biopharmaceutical development by providing Excel...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters